Has Sarah Erskine received payments from drug or device companies?

Yes. Drug and device makers reported $2,468 in general payments to Sarah Erskine across 100 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sarah Erskine did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sarah Erskine come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sarah Erskine

Adult Health · Denison, TXNPI 1972017408

Payments from drug & device makers

$2,468in general payments, 2019–2025

Across 100 payments — averaging $24.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$520
Medtronic$510
SK Life Science, Inc.$341
Eisai Inc.$143
ZOLL Respicardia, Inc.$121
Lilly USA, LLC$118
plus $717 from 17 others

What the payments were for

Travel & lodging$1817%
Food & beverage$2,28793%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	45	$520
Medtronic	8	$510
SK Life Science, Inc.	5	$341
Eisai Inc.	2	$143
ZOLL Respicardia, Inc.	6	$121
Lilly USA, LLC	5	$118
Sumitomo Pharma America, Inc.	4	$86
Lundbeck LLC	3	$76
Inspire Medical Systems, Inc.	2	$66
Harmony Biosciences LLC	2	$64
Jazz Pharmaceuticals Inc.	2	$56
UCB, Inc.	1	$56
Pfizer	3	$46
Avadel CNS Pharmaceuticals, LLC	1	$35
Scilex Pharmaceuticals Inc.	2	$32
Neurelis, Inc.	2	$32
Argenx US, Inc.	1	$31
Biogen	1	$27
Neurocrine Biosciences, Inc.	1	$26
AstraZeneca	1	$25
NS Pharma, Inc.	1	$23
Abbott	1	$21
Amneal Pharmaceuticals LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,468 in reported general payments places this provider in the 80th percentile of 933 adult health providers in Texas.

See all adult health providers in Texas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
QuliptaAtogepant	26	$28,985
Nurtec OdtRimegepant Sulfate	11	$20,197
Memantine Hcl	107	$1,954
Gabapentin	91	$1,849
Duloxetine Hcl	65	$1,038
Carbidopa-LevodopaCarbidopa/Levodopa	81	$822
Levetiracetam	14	$744
Donepezil Hcl	101	$690
Carbidopa-Levodopa ErCarbidopa/Levodopa	23	$575
RivastigmineRivastigmine Tartrate	20	$503
ClopidogrelClopidogrel Bisulfate	12	$251
Lamotrigine	14	$251
Ropinirole Hcl	19	$233
Quetiapine Fumarate	21	$196
Trazodone Hcl	26	$172

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieQulipta	$520	$28,98526 claims
PfizerNurtec Odt	$46	$20,19711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 933 adult health providers in Texas.

Other adult health in Denison

Misty SheddAllen$863K
Melodie YoungDallas$700K
Cynthia BedellPlano$168K
Elizabeth Wedberg SivamAustin$71K
Mary SalazarSan Antonio$68K
Eric KlappholzDallas$44K
Christin TouchetKingwood$43K
Yulia LyuboslavskyAustin$36K
Meghan MurphyAustin$29K
Sandra CareyGrapevine$28K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →